HB-EGF Composition and Use Thereof to Treat a Condition Associated With Enhanced Urothelium Permeability

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130102532A1
SERIAL NO

13641478

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

HB-EGF is exploited to treat conditions associated with enhanced urothelium permeability, including interstitial cystitis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRILLIUM THERAPEUTICS INCTORONTO ONTARIO M9W 4Y9

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Petrova, Penka Toronto, CA 1 0
Uger, Robert Ontario, CA 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation